AFWM
VRTX icon

Abich Financial Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Abich Financial Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$72.8K Buy
+186
New +$77.7K 0.03% 267
2024
Q2 		– Sell
-21
Closed -$8.78K – 880
2024
Q1 		$8.78K Buy
21
+3
+17% +$1.27K 0.01% 225
2023
Q4 		$7.32K Buy
+18
New +$6.65K 0.01% 226

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Abich Financial Wealth Management's VRTX Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2025: 186 shares worth $72.8K. The stake represents 0.03% of the portfolio and ranks #267 among its holdings. This is a return to the name: Abich Financial Wealth Management previously reported a position in VRTX as recently as Q1 2024.

Abich Financial Wealth Management first reported a position in VRTX in Q4 2023 and has held it in 3 quarters since. 1,520 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Abich Financial Wealth Management held 186 shares of Vertex Pharmaceuticals worth $72.8K as of Q3 2025.
  • Vertex Pharmaceuticals was a new Abich Financial Wealth Management position in Q3 2025.
  • Vertex Pharmaceuticals made up 0.03% of Abich Financial Wealth Management's portfolio in Q3 2025, its #267 holding.
  • Abich Financial Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • 1,520 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.